PCRX
Pacira BioSciences, Inc.
25.10$
-0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.1% | +3.2% | +8.4% | +1.3% | -38.6% | +7.0% | -66.1% | +406.4% | -28.2% | -41.2% | +123.8% | – | |
| – | +0.3% | -0.3% | +2.4% | +7.4% | +4.9% | -0.4% | +29.1% | -22.4% | +0.7% | -0.1% | -0.2% | – | |
| – | -0.9% | +5.9% | -4.8% | +5.6% | -7.3% | +18.6% | +6.3% | -9.7% | -3.4% | +0.3% | +10.5% | – | |
| – | – | – | -154.1% | – | -1,265.3% | – | -3,221.1% | – | – | -112.8% | – | – | |
| – | -47.0% | +57.7% | -43.9% | +157.4% | -48.2% | +303.6% | -68.4% | +43.5% | -94.4% | +1,149.5% | -51.0% | – | |
| – | – | -285.5% | -2.0% | +242.8% | -99.3% | +6,864.4% | – | -29.8% | -55.7% | +0.6% | -39.5% | – | |
| – | – | -96.2% | +624,900.0% | – | -100.0% | – | – | +0.0% | -3.6% | +3.7% | +0.0% | – | |
| – | – | – | – | – | 0.0% | +0.0% | +33.3% | +5,373.0% | -97.6% | +0.0% | +0.0% | – | |
| – | -93.6% | +58.3% | – | -111.4% | -31.3% | +53.1% | +1,820.7% | +347.7% | -79.9% | +15.0% | -87.1% | – | |
| – | +340.2% | -43.2% | +104.9% | -101.7% | – | -77.8% | +146.8% | -1,006.1% | – | -230.0% | – | – | |
| – | +11.6% | +1.0% | +11.6% | -3.5% | -37.8% | -13.2% | -65.4% | +511.5% | -23.7% | -47.2% | +144.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.